About BICO Group AB 
BICO Group AB
Pharmaceuticals & Biotechnology
Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company operates as a provider of advanced bioprinting solutions for healthcare sector. The Company offers 3D bioprinting of human tissues and organs. The Company's technology facilitates the biofabrication of cell-laden anatomical structures with controlled cell density and homogenous distribution of viable cells. The cell-laden bioink structures are then cultured in vitro, under controlled conditions for a wide range of experiments. In addition, bioprinting with human cells can be combined with computer-aided design (CAD) and computer-aided manufacturing (CAM) using medical images from CT or MRI scans to create a blueprint (3D model) for bioprinting of patient-specific tissues and organs.
Company Coordinates 
Company Details
Arvid Wallgrens Backe 20 , GOETEBORG None : 413 46
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (1.56%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Carsten Browall
Independent Chairman of the Board
Mr. Erik Gatenholm
Chief Executive Officer, Director
Ms. Ingela Hallberg
Independent Director
Mr. Bengt Sjoholm
Independent Director
Ms. Helena Skantorp
Independent Director
Mr. Christian Wildmoser
Independent Director
Revenue and Profits:
Net Sales:
324 Million
(Quarterly Results - Jun 2025)
Net Profit:
-182 Million
Pharmaceuticals & Biotechnology
SEK 1,384 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.10
-11.60%
0.76






